PHARMACOLOGICAL AND BIOPHYSICAL AGENTS AND BEHAVIOR

By SUSAN GONZALEZ

CONTENTS PART I OVERVIEW DRUG DISCRIMINATION: HISTORICAL ORIGINS, IMPORTANT CONCEPTS, AND PRINCIPLES PART II THE DISCRIMINATIVE STIMULUS PROPERTIES OF DRUGS DISCRIMINATIVE STIMULUS EFFECTS OF PSYCHOSTIMULANTS DISCRIMINATIVE STIMULUS PROPERTIES OF S()-NICOTINE: “A DRUG FOR ALL SEASONS” CROSS-SPECIES TRANSLATIONAL FINDINGS IN THE DISCRIMINATIVE STIMULUS EFFECTS OF ETHANOL DISCRIMINATIVE STIMULUS EFFECTS OF ABUSED INHALANTS THE DISCRIMINATIVE STIMULUS PROPERTIES OF HALLUCINOGENIC AND DISSOCIATIVE ANESTHETIC DRUGS DISCRIMINATIVE STIMULUS PROPERTIES OF PHYTOCANNABINOIDS, ENDOCANNABINOIDS, AND SYNTHETIC CANNABINOIDS DISCRIMINATIVE STIMULUS PROPERTIES OF OPIOID LIGANDS: PROGRESS AND FUTURE DIRECTIONS TRANSLATIONAL VALUE OF DRUG DISCRIMINATION WITH TYPICAL AND ATYPICAL ANTIPSYCHOTIC DRUGS THE DISCRIMINATIVE STIMULUS PROPERTIES OF DRUGS USED TO TREAT DEPRESSION AND ANXIETY PART III APPROACHES TO DRUG DISCRIMINATION PHARMACOKINETIC–PHARMACODYNAMIC (PKPD) ANALYSIS WITH DRUG DISCRIMINATION HUMAN DRUG DISCRIMINATION: ELUCIDATING THE NEUROPHARMACOLOGY OF COMMONLY ABUSED ILLICIT DRUGS CONDITIONED TASTE AVOIDANCE DRUG DISCRIMINATION PROCEDURE: ASSESSMENTS AND APPLICATIONS A PROSPECTIVE EVALUATION OF DRUG DISCRIMINATION IN PHARMACOLOGY